|Bid||85.96 x 800|
|Ask||86.38 x 800|
|Day's Range||85.69 - 87.12|
|52 Week Range||84.86 - 133.11|
|Beta (5Y Monthly)||1.13|
|PE Ratio (TTM)||20.71|
|Earnings Date||Oct 24, 2022 - Oct 28, 2022|
|Forward Dividend & Yield||3.92 (4.47%)|
|Ex-Dividend Date||Jun 29, 2022|
|1y Target Est||106.47|
Subscribe to Yahoo Finance Plus to view Fair Value for BXP
Debt is the lifeblood of real estate investing, especially for real estate investment trusts (REITs). The dividend payout rule means REITs rarely pay debt off completely without unloading properties. Cash flow gets distributed to shareholders or used as a down payment on new properties, and debt eventually gets refinanced and pushed further into the future.
The U.S. inflation rate has surged to levels not seen since the early 1980s. This has had profound ramifications for investors. Sectors such as technology have slumped as folks demand profits and cash flow today rather than growth in the future. Meanwhile, out of favor industries such as energy and natural resources have roared back to life. Real estate investment trusts (or REITs) should find themselves among the winners in this transition. A large part of this is because of how REITs operate.
Two biotech startups co-founded and led by the same chief executive have signed on to take space at a Boston Properties Inc. lab project now under construction in Waltham.